Ach |
acetylcholine |
ATP |
adenosine triphosphate |
BND |
bladder neck dysfunction |
BoNT |
botulinum toxin |
BoNT-A |
Botulinum toxin A |
BPH |
benign prostatic hyperplasia |
CNS |
central nervous system |
DO |
detrusor overactivity |
DSD |
detrusor-sphincter dyssynergia |
DV |
dysfunctional voiding |
IC/BPS |
interstitial cystitis/bladder pain syndrome |
IDO |
idiopathic detrusor overactivity |
IPSS |
international prostate symptom score |
LUTD |
lower urinary tract disease |
LUTS |
lower urinary tract symptoms |
NDO |
neurogenic detrusor overactivity |
NGF |
nerve growth factor |
NO |
nitric oxide |
OAB |
overactive bladder |
P2X |
purinergic receptors |
P2X2 |
P2X purinoceptor 2 |
P2X3 |
P2X purinoceptor 3 |
PKC |
protein kinase C |
SCI |
spinal cord injury |
SNAP |
synaptosomal nerve associated protein |
SNAP-25 |
synaptosomal nerve associated protein 25 |
SNAP-23 |
synaptosomal nerve associated protein 23 |
SNARE |
SNAP receptor |
SV2 |
synaptic vesicle protein |
t-SNARE |
target membrane SNAP receptor |
TRPV1 |
transient receptor potential vanilloid subfamily-1 |
VEGF |
vascular endothelial growth factor |